Skip to main content

Table 1 Characteristics of individual patients.

From: Treatment of esophageal tumors using high intensity intraluminal ultrasound: first clinical results

No. Gender Age Tumor type TNM stage Stricture C/L/T Number of US sessions Other treatments Dysphagia Improvement M1 status M3 status Survival
1 M 80 SCC T3N1M0 360°/30/6 180°/15/6 1 5FU/CDDP 5 > 1 PR Clin: good Obstructive nodule Stent require No tumor progression Clin: good No dysphagia >4 mo
2 M 55 SCC T1N0 110°/10/7 360°/9/9 3 5FU/CDDP 3 > 0 CR, proximal tumorPR, distal tumorClin: goodNo dysphagia PRClin: poor, deteriorating general conditionRecurrent dysphagia 6 mo
3 M 83 AC T3N2M1 360°/30/12 1 5FU 5 > 2    3 wk
4 F 86 SCC T3NxM0 360°/20/7–12 1   5 > 2 PRClin: poorWeight loss (2 kg)   3 mo
  1. SCC, squamous cell carcinoma; AC, adenocarcinoma; TNM, tumor, node, metastasis; C/L/T, circumference/length/thickness of tumor (mm); 5FU, fluorouracil; CDDP, cisplatinum; M1, M3, 1 and 3 months after treatment; clin, clinical status; PR, partial response; CR, complete response; US, ultrasound.